Nalfurafine hydrochloride to treat pruritus: a review

References

• NakaiSHanafusaNMasakaneIAn overview of regular dialysis treatment in Japan (as of December 31, 2012)Ther Apher Dial201418653560225523509
   PubMed Web of Science ®Google Scholar
• PisoniRLWikströmBElderSJPruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)Nephrol Dial Transplant200621123495350516968725
   PubMed Web of Science ®Google Scholar
• NaritaIAlchiBOmoriKEtiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patientsKidney Int20066991626163216672924
   PubMed Web of Science ®Google Scholar
• GunalAIOzalpGYoldasTKGunalSYKircimanECelikerHGabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trialNephrol Dial Transplant200419123137313915575002
   PubMed Web of Science ®Google Scholar
• BrenemanDLCardoneJSBlumsackRFLatherRMSearleEAPollackVETopical capsaicin for treatment of hemodialysis-related pruritusJ Am Acad Dermatol199226191941732343
   PubMed Web of Science ®Google Scholar
• TarngDCChoYLLiuHNHuangTPHemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% creamNephron19967246176228730431
   PubMed Web of Science ®Google Scholar
• GilchrestBARoweJWBrownRSSteinmanTIArndtKAUltraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of actionAnn Intern Med19799111721464448
   PubMed Web of Science ®Google Scholar
• SilvaSRVianaPCLugonNVHoetteMRuzanyFLugonJRThalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trialNephron19946732702737936015
   PubMed Web of Science ®Google Scholar
• SzepietowskiJCSzepietowskiTReichAEfficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary studyActa Dermatovenerol Croat20051329710316324422
   PubMedGoogle Scholar
• Pauli-MagnusCKlumppSAlscherDMKuhlmannUMettangTShort-term efficacy of tacrolimus ointment in severe uremic pruritusPerit Dial Int200020680280311216583
   PubMed Web of Science ®Google Scholar
• KuypersDRClaesKEvenepoelPMaesBVanrenterghemYA prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapyNephrol Dial Transplant20041971895190115150348
   PubMed Web of Science ®Google Scholar
• BalaskasEVUldallRPErythropoietin treatment does not improve uremic pruritusPerit Dial Int19921233303311511055
   PubMed Web of Science ®Google Scholar
• De MarchiSCecchinEVillaltaDSepiacciGSantiniGBartoliERelief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremiaN Engl J Med1992326159699741545849
   PubMed Web of Science ®Google Scholar
• PeerGKivitySAgamiORandomised crossover trial of naltrexone in uraemic pruritusLancet19963489041155215548950882
   PubMed Web of Science ®Google Scholar
• Pauli-MagnusCMikusGAlscherDMNaltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover studyJ Am Soc Nephrol200011351451910703675
   PubMed Web of Science ®Google Scholar
• KumagaiHEbataTTakamoriKMuramatsuTNakamotoHSuzukiHEffect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled studyNephrol Dial Transplant20102541251125719926718
   PubMed Web of Science ®Google Scholar
• Abdelbaqi-SalhabMShalhubSMorganMBA current review of the cutaneous manifestations of renal diseaseJ Cutan Pathol200330952753814507400
   PubMed Web of Science ®Google Scholar
• MettangTKremerAEUremic pruritusKidney Int Epub182014
   Web of Science ®Google Scholar
• MathurVSLindbergJGermainMITCH National Registry InvestigatorsA longitudinal study of uremic pruritus in hemodialysis patientsClin J Am Soc Nephrol2010581410141920558560
   PubMed Web of Science ®Google Scholar
• KleemanCRMassrySGPopovtzerMMMakoffDLMaxwellMHCoburnJWThe disappearance of intractable pruritus after parathyroidectomy in uremic patients with secondary hyperparathyroidismTrans Assoc Am Physicians1968812032125721402
   PubMedGoogle Scholar
• MassrySGPopovtzerMMCoburnJWMakoffDLMaxwellMHKleemanCRIntractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomyN Engl J Med1968279136977005670911
   PubMed Web of Science ®Google Scholar
• Ståhle-BäckdahlMHägermarkOLinsLETörringOHilligesMJohanssonOExperimental and immunohistochemical studies on the possible role of parathyroid hormone in uraemic pruritusJ Intern Med198922564114152746157
   PubMed Web of Science ®Google Scholar
• MettangTFritzPWeberJMachleidtCHübelEKuhlmannUUremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cellsClin Nephrol19903431361411699691
   PubMed Web of Science ®Google Scholar
• StockenhuberFKurzRWSertlKGrimmGBalckePIncreased plasma histamine levels in uraemic pruritusClin Sci (Lond)19907954774822174315
   PubMed Web of Science ®Google Scholar
• WeisshaarEDunkerNRöhlFWGollnickHAntipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patientsExp Dermatol200413529830415140020
   PubMed Web of Science ®Google Scholar
• Dugas-BreitSSchöpfPDugasMSchifflHRuëffFPrzybillaBBaseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritusJ Dtsch Dermatol Ges20053534334716372800
   PubMedGoogle Scholar
• MasmoudiAHajjaji DarouicheMBen SalahHBen HmidaMTurkiHCutaneous abnormalities in patients with end stage renal failure on chronic hemodialysis. A study of 458 patientsJ Dermatol Case Rep201484869425621088
   PubMedGoogle Scholar
• KoulentakiMIoannidouDStefanidouMDermatological manifestations in primary biliary cirrhosis patients: a case control studyAm J Gastroenterol2006101354154616464228
   PubMed Web of Science ®Google Scholar
• TominagaMOzawaSTengaraSOgawaHTakamoriKIntraepidermal nerve fibers increase in dry skin of acetone-treated miceJ Dermatol Sci200748210311117643268
   PubMed Web of Science ®Google Scholar
• JohanssonOHilligesMStåhle-BäckdahlMIntraepidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: evidence for sprouting in uremic patients on maintenance hemodialysisNeurosci Lett19899932812862657508
   PubMed Web of Science ®Google Scholar
• KuraishiYYamaguchiTMiyamotoTItch-scratch responses induced by opioids through central mu opioid receptors in miceJ Biomed Sci20007324825210810244
   PubMed Web of Science ®Google Scholar
• KardonAPPolgárEHachisukaJDynorphin acts as a neuromodulator to inhibit itch in the dorsal horn of the spinal cordNeuron201482357358624726382
   PubMed Web of Science ®Google Scholar
• SzmuszkoviczJVon VoigtlanderPFBenzeneacetamide amines: structurally novel non-m mu opioidsJ Med Chem19822510112511266128415
   PubMed Web of Science ®Google Scholar
• MillanMJKappa-opioid receptors and analgesiaTrends Pharmacol Sci199011270762156363
   PubMed Web of Science ®Google Scholar
• NagaseHHayakawaJKawamuraKDiscovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinanChem Pharm Bull (Tokyo)19984623663699501472
   PubMed Web of Science ®Google Scholar
• PortogheseASLipkowskiAWTakemoriAEBimorphinans as highly selective, potent kappa opioid receptor antagonistsJ Med Chem19873022382393027336
   PubMed Web of Science ®Google Scholar
• PortoghesePSNagaseHLipkowskiAWLarsonDLTakemoriAEBinaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivityJ Med Chem19883148368412832604
   PubMed Web of Science ®Google Scholar
• SekiTAwamuraSKimuraCPharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptorEur J Pharmacol19993761–215916710440101
   PubMed Web of Science ®Google Scholar
• NakaoKIkedaKKurokawaTEffect of TRK-820, a selective kappa opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitisNihon Shinkei Seishin Yakurigaku Zasshi20082827583 Japanese18516986
   PubMedGoogle Scholar
• NakaoKMochizukiHNalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patientsDrugs Today (Barc)200945532332919584962
   PubMed Web of Science ®Google Scholar
• TogashiYUmeuchiHOkanoKAntipruritic activity of the kappa-opioid receptor agonist, TRK-820Eur J Pharmacol20024352–325926411821035
   PubMed Web of Science ®Google Scholar
• UmeuchiHTogashiYHondaTInvolvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid systemEur J Pharmacol20034771293514512095
   PubMed Web of Science ®Google Scholar
• MoriTNomuraMNagaseHNaritaMSuzukiTEffects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in ratsPsychopharmacology (Berl)20021611172211967626
   PubMed Web of Science ®Google Scholar
• WikströmBGellertRLadefogedSDKappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studiesJ Am Soc Nephrol200516123742374716251241
   PubMed Web of Science ®Google Scholar
• KumagaiHEbataTTakamoriKEfficacy and safety of a novel κ-agonist for managing intractable pruritus in dialysis patientsAm J Nephrol201236217518322868684
   PubMed Web of Science ®Google Scholar
• UenoYMoriAYanagitaTOne year long-term study on abuse liability of nalfurafine in hemodialysis patientsInt J Clin Pharmacol Ther2013511182383124040851
   PubMed Web of Science ®Google Scholar
• AraujoSMde BruinVMDaherEFAlmeidaGHMedeirosCAde BruinPFRisk factors for depressive symptoms in a large population on chronic hemodialysisInt Urol Nephrol20124441229123521779919
   PubMed Web of Science ®Google Scholar
• InuiSShirakawaYItamiSEffect of nalfurafine hydrochloride on pruritus and anxiety level in hemodialysis patientsJ Dermatol2012391088688722142516
   PubMed Web of Science ®Google Scholar
• OhSHBaeBGParkCOAssociation of stress with symptoms of atopic dermatitisActa Derm Venereol201090658258821057740
   PubMed Web of Science ®Google Scholar
• GlobeDBaylissMSHarrisonDJThe impact of itch symptoms in psoriasis: results from physician interviews and patient focus groupsHealth Qual Life Outcomes2009716219580674
   PubMed Web of Science ®Google Scholar
• WillebrandMLowADyster-AasJPruritus, personality traits and coping in long-term follow-up of burn-injured patientsActa Derm Venereol200484537538015370704
   PubMed Web of Science ®Google Scholar
• NakazatoKShimonakaYThe Japanese State-Trait Anxiety Inventory: age and sex differencesPercept Mot Skills19896926116172813009
   PubMed Web of Science ®Google Scholar
• TominagaMOgawaHTakamoriKPossible roles of epidermal opioid systems in pruritus of atopic dermatitisJ Invest Dermatol200712792228223517611580
   PubMed Web of Science ®Google Scholar
• NakasoneTSatoTMatsushimaYInoueTKameiCCharacteristics of scratching behavior in ADJM mice (atopic dermatitis from Japanese mice)Immunopharmacol Immunotoxicol Epub1122015
   Web of Science ®Google Scholar
• StincoGTrevisanGPiccirilloFPruritus in chronic plaque psoriasis: a questionnaire-based study of 230 Italian patientsActa Dermatovenerol Croat201422212212825102798
   PubMed Web of Science ®Google Scholar
• MrowietzUChouelaENMallbrisLPruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE studyJ Eur Acad Dermatol Venereol Epub1152014
   Web of Science ®Google Scholar
• AltunayIKAtisGEsenKKucukunalAImpact of functional pruritus compared with mild psoriasis on quality of life: a cross-sectional questionnaire study in TurkeyAm J Clin Dermatol201415436537024756248
   PubMed Web of Science ®Google Scholar
• YosipovitchGGoonAWeeJChanYHGohCLThe prevalence and clinical characteristics of pruritus among patients with extensive psoriasisBr J Dermatol2000143596997311069504
   PubMed Web of Science ®Google Scholar
• TanedaKTominagaMNegiOEvaluation of epidermal nerve density and opioid receptor levels in psoriatic itchBr J Dermatol2011165227728421457210
   PubMed Web of Science ®Google Scholar
• InanSCowanANalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in ratsPharmacol Biochem Behav2006851394316919318
   PubMed Web of Science ®Google Scholar
• UmeuchiHKawashimaYAokiCASpontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochlorideEur J Pharmacol20055182–313313916055114
   PubMed Web of Science ®Google Scholar
• OlatundeAThe practical and therapeutic implications of chloroquine-induced itching in tropical AfricaAfr J Med Med Sci1977612732415540
   PubMedGoogle Scholar
• SpencerHCPoulterNRLuryJDPoulterCJChloroquine-associated pruritus in a EuropeanBr Med J (Clin Res Ed)1982285635617031704
   Web of Science ®Google Scholar
• InanSCowanAKappa opioid agonists suppress chloroquine-induced scratching in miceEur J Pharmacol2004502323323715476749
   PubMed Web of Science ®Google Scholar
• TakasakiINojimaHShirakiKKuraishiYSpecific down-regulation of spinal mu-opioid receptor and reduced analgesic effects of morphine in mice with postherpetic painEur J Pharmacol20065501–3626717026987
   PubMed Web of Science ®Google Scholar
• RaynerHBaharaniJSmithSSureshVDasguptaIUraemic pruritus: relief of itching by gabapentin and pregabalinNephron Clin Pract20121223–4757923548570
   PubMedGoogle Scholar
• YueJJiaoSXiaoYRenWZhaoTMengJComparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind studyInt Urol Nephrol201547116116725099523
   PubMed Web of Science ®Google Scholar